Narita, T
Inagaki, A
Kobayashi, T
Kuroda, Y
Fukushima, T
Nezu, M
Fuchida, S
Sakai, H
Sekiguchi, N
Sugiura, I
Maeda, Y
Takamatsu, H
Tsukamoto, N
Maruyama, D
Kubota, Y
Kojima, M
Sunami, K
Ono, T
Ri, M
Tobinai, K http://orcid.org/0000-0002-7859-3227
Iida, S
Article History
First Online: 27 February 2015
Competing interests
: SI received research funding from the Bristol-Myers Squibb Co., Chugai Pharmaceutical Co. Ltd., Taiho Phamaceutical Co. Ltd., Celgene K.K., Kyowa Hakko Kirin Co., Ltd., Ono Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., Nippon Kayaku Co. Ltd. Honoraria from Janssen Pharmaceutical K.K., Celgene K.K. and Ono Pharmaceutical Co. Ltd. T.H.; Honoraria from Celgene Co., Ltd. KT received Honoraria from Celgene Co., Ltd. Research funding from Taiho Phamaceutical Co. Ltd., Celgene K.K., Ono Pharmaceutical Co. Ltd. Takeda Pharmaceutical Co. Ltd. M.R.; Research funding from Celgene Co., Ltd.